The SH2 Domain Regulates c-Abl Kinase Activation by a Cyclin-Like Mechanism and Remodulation of the Hinge Motion | PLOS Computational Biology
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry | PLOS ONE
Role of ABL family kinases in cancer: from leukaemia to solid tumours | Nature Reviews Cancer
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
JCI - Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
Conformational states dynamically populated by a kinase determine its function | Science
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Opening the door to the development of novel Abl kinase inhibitors | Future Medicinal Chemistry
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction | Encyclopedia MDPI
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors | PNAS
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase: Cell
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
Proposed mechanisms for the regulation of c-Abl tyrosine kinase. The... | Download Scientific Diagram
![PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7afde5a58c37047c83cde7051c4024ff35912884/2-Figure1-1.png "PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar")
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
Identification of the Direct Substrates of the ABL Kinase via Kinase Assay Linked Phosphoproteomics with Multiple Drug Treatments | Journal of Proteome Research
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
